These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 34887864)
21. Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis. Harvima IT; Viinamäki H; Naukkarinen A; Paukkonen K; Neittaanmäki H; Harvima RJ; Horsmanheimo M Psychother Psychosom; 1993; 60(3-4):168-76. PubMed ID: 8272475 [TBL] [Abstract][Full Text] [Related]
22. Mast cells in psoriatic skin are strongly positive for interferon-gamma. Ackermann L; Harvima IT; Pelkonen J; Ritamäki-Salo V; Naukkarinen A; Harvima RJ; Horsmanheimo M Br J Dermatol; 1999 Apr; 140(4):624-33. PubMed ID: 10233311 [TBL] [Abstract][Full Text] [Related]
23. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells. Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823 [TBL] [Abstract][Full Text] [Related]
24. Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis. Killeen ME; Ferris L; Kupetsky EA; Falo L; Mathers AR J Immunol; 2013 Apr; 190(8):4324-36. PubMed ID: 23479230 [TBL] [Abstract][Full Text] [Related]
25. Activation of mast cells mediates inflammatory response in psoriasis: Potential new therapeutic approach with IL-37. Conti P; Gallenga CE; Ronconi G; Caraffa A; Kritas SK Dermatol Ther; 2019 Jul; 32(4):e12943. PubMed ID: 31012218 [TBL] [Abstract][Full Text] [Related]
26. Possible contribution of stem cell factor in psoriasis vulgaris. Yamamoto T; Katayama I; Nishioka K J Dermatol Sci; 2000 Dec; 24(3):171-6. PubMed ID: 11084298 [TBL] [Abstract][Full Text] [Related]
27. Gene from a psoriasis susceptibility locus primes the skin for inflammation. Wolf R; Mascia F; Dharamsi A; Howard OM; Cataisson C; Bliskovski V; Winston J; Feigenbaum L; Lichti U; Ruzicka T; Chavakis T; Yuspa SH Sci Transl Med; 2010 Dec; 2(61):61ra90. PubMed ID: 21148126 [TBL] [Abstract][Full Text] [Related]
28. Suprabasin-derived polypeptides: SBSN(50-63) induces inflammatory response via TLR4-mediated mast cell activation. Zhou T; Du X; Zhang L; Zheng Y; Jia T; Song X; Che D; Geng S Inflammopharmacology; 2023 Jun; 31(3):1329-1339. PubMed ID: 36745245 [TBL] [Abstract][Full Text] [Related]
29. Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cells. Vasiadi M; Therianou A; Alysandratos KD; Katsarou-Katsari A; Petrakopoulou T; Theoharides A; Papadavid E; Stavrianeas N; Antoniou C; Kalogeromitros D; Theoharides TC Br J Dermatol; 2012 Jun; 166(6):1349-52. PubMed ID: 22283733 [TBL] [Abstract][Full Text] [Related]
30. Neuroblast Differentiation-Associated Protein Derived Polypeptides: AHNAK(5758-5775) Induces Inflammation by Activating Mast Cells via ST2. Song X; Zhang L; Du X; Zheng Y; Jia T; Zhou T; Che D; Geng S Immunol Invest; 2023 Feb; 52(2):178-193. PubMed ID: 36511894 [TBL] [Abstract][Full Text] [Related]
31. Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. Singh TP; Schön MP; Wallbrecht K; Gruber-Wackernagel A; Wang XJ; Wolf P PLoS One; 2013; 8(1):e51752. PubMed ID: 23335955 [TBL] [Abstract][Full Text] [Related]
32. Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin. Keijsers RR; van der Velden HM; van Erp PE; de Boer-van Huizen RT; Joosten I; Koenen HJ; van de Kerkhof PC Br J Dermatol; 2013 Jun; 168(6):1294-302. PubMed ID: 23330679 [TBL] [Abstract][Full Text] [Related]
33. Defective Induction of COX-2 Expression by Psoriatic Fibroblasts Promotes Pro-inflammatory Activation of Macrophages. Arasa J; Terencio MC; Andrés RM; Marín-Castejón A; Valcuende-Cavero F; Payá M; Montesinos MC Front Immunol; 2019; 10():536. PubMed ID: 30984165 [TBL] [Abstract][Full Text] [Related]
34. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis. Lovato P; Norsgaard H; Tokura Y; Røpke MA J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805 [TBL] [Abstract][Full Text] [Related]
35. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. Nestle FO; Turka LA; Nickoloff BJ J Clin Invest; 1994 Jul; 94(1):202-9. PubMed ID: 8040262 [TBL] [Abstract][Full Text] [Related]
36. Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients. D'Amico F; Granata M; Skarmoutsou E; Trovato C; Lovero G; Gangemi P; Longo V; Pettinato M; Mazzarino MC Inflamm Res; 2018 Jul; 67(7):609-616. PubMed ID: 29605872 [TBL] [Abstract][Full Text] [Related]